Patients should be informed when AI systems are used in clinical trials

被引：9
|
作者：
Perni, Subha [1 ,2 ,3 ]
Lehmann, Lisa Soleymani [2 ,4 ]
Bitterman, Danielle S. [1 ,2 ]
机构：
[1] Harvard Med Sch, Artificial Intelligence Med Program, Mass Gen Brigham, Boston, MA 02115 USA
[2] Harvard Med Sch, Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA
[3] Univ Texas TMD Anderson Canc Ctr, Houston, TX USA
[4] Harvard Med Sch, Harvard TH Chan Sch Publ Hlth, Boston, MA USA
来源：
NATURE MEDICINE | 2023年 / 29卷 / 08期
关键词：
ARTIFICIAL-INTELLIGENCE;
D O I：
10.1038/s41591-023-02367-8
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：1890 / 1891
页数：2
相关论文
共 50 条
  • [1] Patients should be informed when AI systems are used in clinical trials
    Subha Perni
    Lisa Soleymani Lehmann
    Danielle S. Bitterman
    Nature Medicine, 2023, 29 : 1890 - 1891
  • [2] Adaptive Methods: When and How Should They be Used in Clinical Trials?
    Porcher, Raphael
    Lecocq, Brigitte
    Vray, Muriel
    THERAPIE, 2011, 66 (04): : 319 - 326
  • [3] Composite outcomes in clinical trials: what are they and when should they be used?
    Heddle, Nancy M.
    Cook, Richard J.
    TRANSFUSION, 2011, 51 (01) : 11 - 13
  • [4] When should ace inhibitors be used in IDDM patients? A combined analysis of clinical trials
    DIABETOLOGIA, 1998, 41 : A4 - A4
  • [5] Issues around informed consent - Why and when should women participate in clinical trials?
    Goodare, H
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S128 - S128
  • [6] INFORMED CONSENT IN CLINICAL-TRIALS - SHOULD BE COMPREHENSIVE ...
    EMBERTON, M
    WOOD, C
    MEREDITH, P
    BRITISH MEDICAL JOURNAL, 1993, 307 (6917): : 1494 - 1494
  • [7] When should Factorial Designs be used for Randomised Controlled Trials?
    Szubert, Alexander J.
    Walker, A. Sarah
    Parmar, Mahesh K. B.
    White, Ian R.
    TRIALS, 2019, 20
  • [8] How AI is being used to accelerate clinical trials
    Hutson, Matthew
    NATURE, 2024, 627 (8003) : S2 - S5
  • [9] When should matching be used in the design of cluster randomized trials?
    Chondros, Patty
    Ukoumunne, Obioha C.
    Gunn, Jane M.
    Carlin, John B.
    STATISTICS IN MEDICINE, 2021, 40 (26) : 5765 - 5778
  • [10] No, Maintenance Treatment Should Not Be Used Outside Clinical Trials
    Vesole, David H.
    Siegel, David S.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (03) : 163 - +
12345